-
1
-
-
0027243348
-
Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II)
-
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
-
(1993)
JAMA
, vol.269
, pp. 3015-3023
-
-
-
2
-
-
0023930868
-
Report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults
-
The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med. 1988;148:36-69.
-
(1988)
Arch Intern Med
, vol.148
, pp. 36-69
-
-
-
3
-
-
0024406675
-
Impact of national guidelines for cholesterol risk screening: The Framingham offspring study
-
Wilson PWF, Christiansen JC, Anderson KM, Kannel WB. Impact of national guidelines for cholesterol risk screening: the Framingham Offspring Study. JAMA. 1989;262:41-44.
-
(1989)
JAMA
, vol.262
, pp. 41-44
-
-
Wilson, P.W.F.1
Christiansen, J.C.2
Anderson, K.M.3
Kannel, W.B.4
-
4
-
-
0024406676
-
The prevalence of high blood cholesterol levels among adults in the United States
-
Sempos C, Fulwood R, Haines C, Carroll M, Anda R, Williamson DF, Remington P, Cleeman J. The prevalence of high blood cholesterol levels among adults in the United States. JAMA. 1989;262:45-52.
-
(1989)
JAMA
, vol.262
, pp. 45-52
-
-
Sempos, C.1
Fulwood, R.2
Haines, C.3
Carroll, M.4
Anda, R.5
Williamson, D.F.6
Remington, P.7
Cleeman, J.8
-
5
-
-
0024405294
-
Relative impact of targeted versus populationwide cholesterol interventions on the incidence of coronary heart disease
-
Goldman L, Weinstein MC, Williams LW. Relative impact of targeted versus populationwide cholesterol interventions on the incidence of coronary heart disease. Circulation. 1989;80:254-260.
-
(1989)
Circulation
, vol.80
, pp. 254-260
-
-
Goldman, L.1
Weinstein, M.C.2
Williams, L.W.3
-
6
-
-
0021826599
-
Projected effects of high-risk versus population-based preventions strategies in coronary heart disease
-
Kottke TE, Puska P, Salonen JT, Tuomilehto J, Nissinen A. Projected effects of high-risk versus population-based preventions strategies in coronary heart disease. Am J Epidemiol. 1985;121:697-704.
-
(1985)
Am J Epidemiol
, vol.121
, pp. 697-704
-
-
Kottke, T.E.1
Puska, P.2
Salonen, J.T.3
Tuomilehto, J.4
Nissinen, A.5
-
7
-
-
0026090020
-
Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease
-
Goldman L, Weinstein MC, Goldman PA, Williams LW. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA. 1991;265:1145-1151.
-
(1991)
JAMA
, vol.265
, pp. 1145-1151
-
-
Goldman, L.1
Weinstein, M.C.2
Goldman, P.A.3
Williams, L.W.4
-
9
-
-
0025674465
-
Reducing high blood cholesterol with drugs: Cost-effectiveness of pharmacologic management
-
Schulman K, Kinosian B, Jacobson T, Glick H, Eisenberg JM. Reducing high blood cholesterol with drugs: cost-effectiveness of pharmacologic management. JAMA. 1990;264:3025-3033.
-
(1990)
JAMA
, vol.264
, pp. 3025-3033
-
-
Schulman, K.1
Kinosian, B.2
Jacobson, T.3
Glick, H.4
Eisenberg, J.M.5
-
10
-
-
0028927214
-
The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease: Estimating the benefits of increasing HDL-C
-
Hamilton VH, Racicot FE, Zowall H, Coupal L, Grover SA. The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease: estimating the benefits of increasing HDL-C. JAMA. 1995;273:1032-1038.
-
(1995)
JAMA
, vol.273
, pp. 1032-1038
-
-
Hamilton, V.H.1
Racicot, F.E.2
Zowall, H.3
Coupal, L.4
Grover, S.A.5
-
11
-
-
0029883280
-
Cholesterol lowering and the use of health care resources: Results of the Scandinavian simvistatin survival study
-
Pedersen TR, Kjekshus J, Berg K, Olsson AG, Wilhelmsen L, Wedel H, Pyörälä K, Miettinen T, Haghfelt T, Færgeman O, Thorgeirsson G, Jönsson B, Schwartz JS, for the Scandinavian Simvistatin Survival Group. Cholesterol lowering and the use of health care resources: results of the Scandinavian Simvistatin Survival Study. Circulation. 1996;93:1796-1802.
-
(1996)
Circulation
, vol.93
, pp. 1796-1802
-
-
Pedersen, T.R.1
Kjekshus, J.2
Berg, K.3
Olsson, A.G.4
Wilhelmsen, L.5
Wedel, H.6
Pyörälä, K.7
Miettinen, T.8
Haghfelt, T.9
Færgeman, O.10
Thorgeirsson, G.11
Jönsson, B.12
Schwartz, J.S.13
-
12
-
-
0026517956
-
Cost and health implications of cholesterol lowering
-
Goldman L, Gordon DJ, Rifkind BM, Hulley SB, Detsky AS, Goodman DS, Kinosian B, Weinstein MC. Cost and health implications of cholesterol lowering. Circulation. 1992;85:1960-1968.
-
(1992)
Circulation
, vol.85
, pp. 1960-1968
-
-
Goldman, L.1
Gordon, D.J.2
Rifkind, B.M.3
Hulley, S.B.4
Detsky, A.S.5
Goodman, D.S.6
Kinosian, B.7
Weinstein, M.C.8
-
13
-
-
0025764923
-
Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: Is individual intervention worth while?
-
Kristiansen IS, Eggen AE, Thelle DS. Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while? Br Med J. 1991;302:1119-1122.
-
(1991)
Br Med J
, vol.302
, pp. 1119-1122
-
-
Kristiansen, I.S.1
Eggen, A.E.2
Thelle, D.S.3
|